DZNE Ulm participates in two collaborative research centers with projects on Parkinson's
Prof. Karin Danzer, neuroscientist at the DZNE Ulm site, has received about 460,000 euros as a member of…
Hans and Ilse Breuer Foundation awards Alzheimer's doctoral fellowship 2023 to DZNE
In order to promote young scientists in the field of dementia research in Germany, the Frankfurt Hans and Ilse…
Portrait on WDR Lokalzeit: DZNE researcher Prof. Monique M.B. Breteler
Prof. Monique M.B. Breteler is Director of Population Health Research and head of the Rhineland Study. The renowned Dutch…
Description and scope of data processing
Our website offers people who provide their personal data the option to register for intermittent contact that will enable them to receive information on…
Human Frontier Science Program funds transatlantic research project.
Human Frontier Science Program funds transatlantic research project
Berlin/Bonn, May 5, 2023. An international research team,…
„Donanemab“: Novel Drug Slows Cognitive Decline in Alzheimer’s Disease
In a clinical trial, a novel drug called „Donanemab” has led to a slowing of cognitive decline in people with early…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
